Covid-19 may affect the brain’s dopamine and serotonin levels.
Adapted from a medical file created by freepik. A population-sized study found that 18% of Covid-19 survivors had psychiatric diagnoses.
We may finally see that wave today. 18% of Covid-19 survivors develop a mental health problem within 14 to 90 days of being hospitalized, according to a paper published this month. 18% is huge considering the scale that has exceeded 57 million cases and 1.3 million deaths.
The research review was titled “Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19?” There are neurological symptoms and possible immune mechanisms. The review draws on past epidemics and Pandemics to infer what might happen after the Covid-19 pandemic.
Researchers at the University of Oxford identified more than 60,000 cases of Covid-19 using the TriNetX Analytics Network, which stores health data of nearly 70 million patients across 54 healthcare organizations in the U.S. The study did something.
People have been worried that Covid-19 survivors will be at greater risk of mental health problems. The study controlled for 50 other factors that could affect the results, which include age, sex, race, socio-economic factors, nicotine dependence, and comorbidities.
Even in Covid-19 cases that don’t require hospital care, the risk of a mental health problem remains 1.5 to 2 times higher. The authors wrote that the elevated risk of psychiatric sequelae after Covid-19 diagnosis could not be explained by differences in illness severity. I would keep an open mind until further studies show that mild Covid-19 can affect a person’s mental health.
They found that 18% of Covid-19 survivors received a psychiatry diagnosis within 14 to 90 days of their infections, of which 5.8% had no history of psychiatric disorder. Compared to groups with a non- Covid health event, the rates of recurrent and first-time diagnoses are up to 2-fold. Mood disorders, anxiety disorders, and insomnia were the most common diagnoses.
The study found that a history of mental health problems led to a 1.6-fold increased risk of positive Covid-19 diagnosis. Pre-existing disorders count as comorbidities that increase the risk of more severe Covid-19. According to the study, having a mental health problem should be added to the list of risk factors. Paul Harrison, a professor of psychiatry at the University of Oxford who directed the study, said that people have been worried that Covid-19 survivors will be at greater risk of mental health problems.
Results must be interpreted in light of the study caveat. Despite already accounting for 50 covariates, the authors admitted that overlooked covariate may still be present. The geographical limitation to the U.S. is a downside. The lack of severity or diagnostic criteria is a serious limitation that may undermine the study. In this study, the depression diagnosed and anxiety cases may be less severe than major depression or anxiety disorders.
There is a biomolecular underpinning. James C. Coyne, a health psychology professor at the University Medical Center Groningen, critiqued that the front liners may not have made diagnoses as accurate as a psychiatrist. He said that a structured psychiatric interview can take up to 90 minutes. In this study, the depression diagnosed and anxiety cases may be less severe than major depression or anxiety disorders.
The ACE2/DDC pathway is part I. Covid-19 survivors have a 1.5–2 times increased rate of future psychiatric diagnoses than survivors of other health events. Why is Covid-19 more closely linked to Psychiatry than other health events?
A paper was published last month in the European Journal of Psychiatry that stated that a DDC malfunction might be related to a SARS-CoV-2- induced defective expression of ACE2 in Covid19 patients. The Covid-19) uses the receptor ACE2 to enter cells. Dopa decarboxylase is involved in the production of dopamine and serotonin, which are involved in anxiety and depression. The ACE2 receptor is lowered on the cell by the presence of SARS-CoV-2. The production of dopamine and serotonin is halted.
The tendency to target the ACE2 receptor may be why the mental health consequences of the disease are more severe than other health events. The expression of ACE2 is lowered by the SARS-CoV-2. The normal function of ACE2 is to convert angiotensin II to angiotensin 1–7. Angiotensin II would increase if ACE2 decreased. The problem is that angiotensin II leads to inflammation and stress in the brain, which leads to depression and anxiety.
One of the best-studied pathways in depression and anxiety is the tryptophan/KYN pathway. The brain’s serotonin levels are influenced by the TRP/KYN pathway when tryptophan crosses the blood-brain-barrier. The second part of the pathway is called the TRP/KYN pathway.
A research review published this month in The Neuroscience states that patients affected by severe Covid-19 with long-term inflammation may have long-term neurological sequels. The pathway starts when pro- inflammatory cytokines cause indoleamine 2,3-dioxygenase to be activated. IDO-1 degrades TRP into KYN to suppress inflammation. Serotonin production is compromised when TRP is lost. Since IDO-1 is present in the brain, inflammation would lead to a decrease in the levels of the neurotransmitter.
Compared to survivors of non- Covid health events, Covid-19 survivors have an increased rate of recurrent and first-time psychiatric diagnoses. 18% of Covid-19 survivors had a mental health problem, most commonly anxiety, depression, and insomnia. The tendency to target the ACE2 receptor may be why it is more likely to be involved in the aftermath of a mental health event. An abstract.
There is a critique that the diagnoses made by the Lancet study may not be as accurate as the psychiatrists’. The study may have found depression and anxiety that isn’t as severe as major depression or anxiety disorders. There may be a wave of mental health disorders. Mental health crisis may be at an all-time high due to income loss, bereavement, and social isolation.
Was this helpful?
0 / 0